Vitamin B Derivative Reduces Risk for Further Skin Cancer

Zosia Chustecka

An inexpensive vitamin B₃ product, widely available over the counter, has been shown to reduce significantly the risk of developing further skin cancers in patients who have already been diagnosed with nonmelanoma skin cancer. The product is nicotinamide, taken orally 500 mg twice daily.

Read more...

Therapeutic Efficacy of Interleukin 12 / Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status

Source: JAMA Dermatol  

Arakawa A, Ruzicka T, Prinz J; JAMA Dermatology (Apr 2016)

Tags: 

acitretin

Psoriasis

ustekinumab 

Read more...

Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool

Source: JAMA Ophthalmol  

Aziz H, Singh N, Bena J, Wilkinson A, Singh A; JAMA Ophthalmology (Apr 2016)

Tags: 

Melanoma 

Read more...

Treatment of Infantile Hemangiomas With Beta-Blockers

A Review

Sonal Shah, MD, Ilona J. Frieden, MD

Disclosures

Skin Therapy Letter. 2013;18(6) 

Abstract and Introduction

Pathogenesis of Infantile Hemangiomas

Mechanism of Action of β-blockers on Infantile Hemangiomas

Mechanism of Action of β-blockers on Infantile Hemangiomas

Hemangiomas in Special Anatomic Sites

Ulceration

Rebound Growth

Side Effects

Initiation of Propranolol

Other β-blockers

Topical β-blockers

Conclusion

References 

Read more...